Page last updated: 2024-11-07

chitotriose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Chitotriose is a trisaccharide composed of three N-acetylglucosamine (GlcNAc) units linked by β-1,4-glycosidic bonds. It is a degradation product of chitin, a naturally occurring polysaccharide found in the exoskeletons of arthropods and the cell walls of fungi. Chitotriose is also found in some bacterial cell walls. The synthesis of chitotriose can be achieved through enzymatic or chemical methods. Enzymatic methods typically involve the use of chitinases, which are enzymes that can hydrolyze chitin to produce chitotriose and other oligosaccharides. Chemical methods involve the depolymerization of chitin using strong acids or bases. Chitotriose has been shown to have various biological activities. It is a potent inducer of the immune response and can stimulate the production of cytokines, such as TNF-α and IL-6. Chitotriose is also known to have anti-inflammatory and anti-tumor properties. Chitotriose is studied because of its potential applications in various fields, including medicine, agriculture, and food science. In medicine, it is being investigated as a potential therapeutic agent for various diseases, such as inflammatory bowel disease, rheumatoid arthritis, and cancer. In agriculture, it can be used as a biopesticide and a biostimulant for plant growth. In food science, it is being explored as a potential prebiotic that can promote the growth of beneficial bacteria in the gut. Chitotriose is a promising compound with a wide range of potential applications.'

chitotriose : An amino trisaccharide comprising of three 2-amino-2-deoxy-D-glucopyranose units joined by beta-(1->4) linkages. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID121978
MeSH IDM0122207

Synonyms (12)

Synonym
chitotriose
chitintriose
(2r,3r,4s,5r)-2-amino-4-[(2s,3r,4r,5s,6r)-3-amino-5-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5,6-trihydroxyhexanal
41708-93-4
d-glucose, o-2-amino-2-deoxy-beta-d-glucopyranosyl-(1-4)-o-2-amino-2-deoxy-beta-d-glucopyranosyl-(1-4)-2-amino-2-deoxy-
chitotrisaccharide
(2r,3r,4s,5r)-2-amino-4-{[(2s,3r,4r,5s,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5,6-trihydroxyhexanal
o-2-amino-2-deoxy-beta-d-glucopyranosyl-(1->4)-o-2-amino-2-deoxy-beta-d-glucopyranosyl-(1->4)-2-amino-2-deoxy-d-glucose
o-2-amino-2-deoxy-beta-delta-glucopyranosyl-(1->4)-o-2-amino-2-deoxy-beta-delta-glucopyranosyl-(1->4)-2-amino-2-deoxy-delta-glucose
HBAVVSYNWHLVDB-UDAFUQIYSA-N
(2r,3r,4r,5r)-2-amino-4-[(2r,3r,4r,5s,6r)-3-amino-5-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5,6-trihydroxy-hexanal
DTXSID401319111

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic analysis of chitobiose and chitotriose after intravenous administration at 100 mg/kg revealed that both sugars were eliminated from the body following a one-compartment model and that the former relative to the latter was higher for both the total body clearance (224+/-43 vs."( Pharmacokinetics of chitobiose and chitotriose administered intravenously or orally to rats.
Chen, AS; Danjo, K; Matahira, Y; Miwa, I; Okamoto, H; Sakai, K; Taguchi, T; Wang, MW, 2005
)
0.87

Bioavailability

ExcerptReferenceRelevance
" The absolute oral bioavailability of chitobiose was higher than that of chitotriose at all doses (30, 100, and 300 mg/kg) examined."( Pharmacokinetics of chitobiose and chitotriose administered intravenously or orally to rats.
Chen, AS; Danjo, K; Matahira, Y; Miwa, I; Okamoto, H; Sakai, K; Taguchi, T; Wang, MW, 2005
)
0.84
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (5.56)18.7374
1990's15 (27.78)18.2507
2000's17 (31.48)29.6817
2010's16 (29.63)24.3611
2020's3 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.44 (24.57)
Research Supply Index4.01 (2.92)
Research Growth Index5.11 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other54 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]